Title:
がんマーカーおよびその用途
Document Type and Number:
Japanese Patent JP7432578
Kind Code:
B2
Abstract:
Provided is a novel cancer marker for testing the risk of developing a cancer. This cancer marker includes at least one substance selected from the group consisting of anti-HIRIP3 antibodies, HIRIP3, anti-FNDC11 antibodies, FNDC11, anti-SLC1A3 antibodies, SLC1A3, anti-TMEM33 antibodies, TMEM33, anti-ABCF1 antibodies, ABCF1, anti-CFDP1 antibodies, CFDP1, anti-POLR3GL antibodies, POLR3GL, anti-CADM1 antibodies, CADM1, anti-RNF128 antibodies, RNF128, anti-ATP6V1B1 antibodies, and ATP6V1B1.
Inventors:
Hiroyuki Takeda
Tatsuya Sawazaki
Yoshihiro Miyake
Youhei Miyagi
Tomoyuki Yokose
Toshinari Yamashita
Tatsuya Sawazaki
Yoshihiro Miyake
Youhei Miyagi
Tomoyuki Yokose
Toshinari Yamashita
Application Number:
JP2021505075A
Publication Date:
February 16, 2024
Filing Date:
March 10, 2020
Export Citation:
Assignee:
Sysmex Corporation
International Classes:
G01N33/574; C07K14/47; C07K16/18; C12Q1/6844; G01N33/15; G01N33/50; G01N33/53
Domestic Patent References:
| JP2017083455A | ||||
| JP2017131218A |
Other References:
LORAIN, Stephanie et al., Core Histones and HIRIP3, a novel Histone-Binding Protein, Directly Interact with WD Repeat Protei,Molecular and Cellular Biology,1998年09月,Vol.18,No.9,PP.5546-5556
Attorney, Agent or Firm:
Koichiro Tsujimaru
Masato Matsunawa
Isaji Sou
Shuo An
Masato Matsunawa
Isaji Sou
Shuo An